GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dianthus Therapeutics Inc (FRA:87E) » Definitions » Other Current Receivables

Dianthus Therapeutics (FRA:87E) Other Current Receivables : €0.00 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Dianthus Therapeutics Other Current Receivables?

Dianthus Therapeutics's Other Current Receivables for the quarter that ended in Mar. 2025 was €0.00 Mil.

Dianthus Therapeutics's quarterly Other Current Receivables declined from Sep. 2024 (€2.42 Mil) to Dec. 2024 (€0.77 Mil) but then stayed the same from Dec. 2024 (€0.77 Mil) to Mar. 2025 (€0.00 Mil).

Dianthus Therapeutics's annual Other Current Receivables declined from Dec. 2022 (€5.32 Mil) to Dec. 2023 (€0.44 Mil) but then increased from Dec. 2023 (€0.44 Mil) to Dec. 2024 (€0.77 Mil).


Dianthus Therapeutics Other Current Receivables Historical Data

The historical data trend for Dianthus Therapeutics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dianthus Therapeutics Other Current Receivables Chart

Dianthus Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Current Receivables
1.31 5.32 0.44 0.77

Dianthus Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 1.56 2.42 0.77 -

Dianthus Therapeutics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Dianthus Therapeutics Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Dianthus Therapeutics's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Dianthus Therapeutics Business Description

Traded in Other Exchanges
Address
7 Times Square, 43rd Floor, New York, NY, USA, 10036
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Dianthus Therapeutics Headlines

No Headlines